US Patent Issued to Elanco US on Aug. 11 for "NGF antagonists for medical use" (California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,753, issued on Aug. 11, was assigned to Elanco US Inc. (Greenfield, Ind.).

"NGF antagonists for medical use" was invented by Hangjun Zhan (Foster City, Calif.), Lam Nguyen (Union City, Calif.), Richard Chin (San Francisco), Fawn Qian (Burlingame, Calif.), Shyr Jiann Li (Millbrae, Calif.) and Qingyi Chu (Burlingame, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are various embodiments relating to TrkA ECD polypeptides from companion animal species that bind to NGF. Such polypeptides can be used in methods to treat NGF-induced condition related to chronic pain and/or inflammatory pain in companion animals, such as canines, felines, an...